Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Differential Helicobacter pylori Plasticity in the Gastric Niche of Subjects at Increased Gastric Cancer Risk.

Casarotto M, Pratesi C, Bidoli E, Maiero S, Magris R, Steffan A, Basaglia G, Canzonieri V, De Re V, Cannizzaro R, Zanussi S.

Pathogens. 2019 May 18;8(2). pii: E65. doi: 10.3390/pathogens8020065.

2.

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer.

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.

Cancers (Basel). 2019 May 10;11(5). pii: E648. doi: 10.3390/cancers11050648.

3.

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients.

Cangemi M, Montico B, Faè DA, Steffan A, Dolcetti R.

Front Oncol. 2019 Mar 27;9:160. doi: 10.3389/fonc.2019.00160. eCollection 2019. Review.

4.

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.

De Re V, Tornesello ML, De Zorzi M, Caggiari L, Pezzuto F, Leone P, Racanelli V, Lauletta G, Gragnani L, Buonadonna A, Vaccher E, Zignego AL, Steffan A, Buonaguro FM.

Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.

5.

The metabolomic scent of cancer disease progression in soft tissue sarcoma: A case report.

Miolo G, Basile D, Carretta A, Santeufemia DA, Steffan A, Corona G.

Int J Biol Markers. 2019 Mar 11:1724600818817316. doi: 10.1177/1724600818817316. [Epub ahead of print]

PMID:
30852948
6.

Microfluidic droplets content classification and analysis through convolutional neural networks in a liquid biopsy workflow.

Soldati G, Del Ben F, Brisotto G, Biscontin E, Bulfoni M, Piruska A, Steffan A, Turetta M, Della Mea V.

Am J Transl Res. 2018 Dec 15;10(12):4004-4016. eCollection 2018.

7.

Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells.

Turetta M, Bulfoni M, Brisotto G, Fasola G, Zanello A, Biscontin E, Mariuzzi L, Steffan A, Di Loreto C, Cesselli D, Del Ben F.

Cancers (Basel). 2018 Aug 14;10(8). pii: E270. doi: 10.3390/cancers10080270.

8.

Acquired factor XII deficiency following transanal excision of rectal lesion by transanal minimally invasive surgery (TAMIS): a case report and literature review.

Cozzi MR, Lauretta A, Vettori R, Steffan A.

World J Surg Oncol. 2018 Jun 19;16(1):115. doi: 10.1186/s12957-018-1410-x. Review.

9.

Rapid LC-MS/MS method for quantification of vinorelbine and 4-O-deacetylvinorelbine in human whole blood suitable to monitoring oral metronomic anticancer therapy.

Corona G, Gusella M, Gaspardo A, Miolo G, Bertolaso L, Pezzolo E, Pasini F, Steffan A, Caruso D.

Biomed Chromatogr. 2018 May 10:e4282. doi: 10.1002/bmc.4282. [Epub ahead of print]

PMID:
29749011
10.

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.

Repetto O, Maiero S, Magris R, Miolo G, Cozzi MR, Steffan A, Canzonieri V, Cannizzaro R, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E759. doi: 10.3390/ijms19030759.

11.

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.

Corona G, Cannizzaro R, Miolo G, Caggiari L, De Zorzi M, Repetto O, Steffan A, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E750. doi: 10.3390/ijms19030750.

12.

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

Caggiari L, Miolo G, Buonadonna A, Basile D, Santeufemia DA, Cossu A, Palmieri G, De Zorzi M, Fornasarig M, Alessandrini L, Canzonieri V, Lo Re G, Puglisi F, Steffan A, Cannizzaro R, De Re V.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E47. doi: 10.3390/ijms19010047.

13.

Cancer Targeted Therapy Strategy: The Pathologist's Perspectives.

Alessandrini L, Perin T, Kadare S, Del Pup L, Memeo L, Steffan A, Colarossi L, Berretta M, De Paoli P, Canzonieri V.

Curr Cancer Drug Targets. 2018;18(5):410-420. doi: 10.2174/1568009618666171129145703.

PMID:
29189158
14.

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.

Tripodi A, Ageno W, Ciaccio M, Legnani C, Lippi G, Manotti C, Marcucci R, Moia M, Morelli B, Poli D, Steffan A, Testa S.

Blood Transfus. 2018 Sep;16(5):462-470. doi: 10.2450/2017.0124-17. Epub 2017 Sep 13.

15.

Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression.

Baglio SR, Lagerweij T, Pérez-Lanzón M, Ho XD, Léveillé N, Melo SA, Cleton-Jansen AM, Jordanova ES, Roncuzzi L, Greco M, van Eijndhoven MAJ, Grisendi G, Dominici M, Bonafede R, Lougheed SM, de Gruijl TD, Zini N, Cervo S, Steffan A, Canzonieri V, Martson A, Maasalu K, Köks S, Wurdinger T, Baldini N, Pegtel DM.

Clin Cancer Res. 2017 Jul 15;23(14):3721-3733. doi: 10.1158/1078-0432.CCR-16-2726. Epub 2017 Jan 4. Erratum in: Clin Cancer Res. 2018 Feb 1;24(3):724.

16.

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.

De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R.

Clin Transl Gastroenterol. 2016 Jul 21;7(7):e183. doi: 10.1038/ctg.2016.42.

17.

Drafting biological material transfer agreement: a ready-to-sign model for biobanks and biorepositories.

Cervo S, De Paoli P, Mestroni E, Perin T, Escoffier L, Canzonieri V, Steffan A.

Int J Biol Markers. 2016 May 28;31(2):e211-7. doi: 10.5301/jbm.5000190.

PMID:
26868333
18.

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.

Romagnolo C, Leon AE, Fabricio ASC, Taborelli M, Polesel J, Del Pup L, Steffan A, Cervo S, Ravaggi A, Zanotti L, Bandiera E, Odicino FE, Scattolo N, Squarcina E, Papadakis C, Maggino T, Gion M.

Gynecol Oncol. 2016 May;141(2):303-311. doi: 10.1016/j.ygyno.2016.01.016. Epub 2016 Jan 19.

PMID:
26801941
19.

The upper reference limit for thyroid peroxidase autoantibodies is method-dependent: A collaborative study with biomedical industries.

Tozzoli R, D'Aurizio F, Ferrari A, Castello R, Metus P, Caruso B, Perosa AR, Sirianni F, Stenner E, Steffan A, Villalta D.

Clin Chim Acta. 2016 Jan 15;452:61-5. doi: 10.1016/j.cca.2015.10.025. Epub 2015 Oct 28.

PMID:
26519836
20.

Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis.

Furlan C, Steffan A, Polesel J, Trovo M, Gobitti C, Vaccher E, Serraino D, Barzan L, Franchin G.

Biomark Res. 2015 Oct 6;3:25. doi: 10.1186/s40364-015-0051-2. eCollection 2015.

Supplemental Content

Loading ...
Support Center